Stockreport

Ocular Therapeutix (NASDAQ:OCUL) Surprises With Q3 CY2025 Sales [Yahoo! Finance]

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com
PDF Its non-GAAP loss of $0.38 per share was 9.6% below analysts' consensus estimates. Is now the time to buy Ocular Therapeutix? Find out in our full research report Re [Read more]